Biomics Biopharma (ASX:BBM) Gross-Profit-to-Asset % : 0.00% (As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Biomics Biopharma's annualized Gross Profit for the quarter that ended in . 20 was A$ Mil. Biomics Biopharma's average Total Assets over the quarter that ended in . 20 was A$ 0 Mil. Therefore, Biomics Biopharma's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.

Biomics Biopharma Gross-Profit-to-Asset % Historical Data

The historical data trend for Biomics Biopharma's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Gross-Profit-to-Asset % Chart

Biomics Biopharma Annual Data

Trend

Gross-Profit-to-Asset %

Biomics Biopharma Semi-Annual Data

Gross-Profit-to-Asset %

Competitive Comparison of Biomics Biopharma's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Biomics Biopharma's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomics Biopharma's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomics Biopharma's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Biomics Biopharma's Gross-Profit-to-Asset % falls into.

Biomics Biopharma Gross-Profit-to-Asset % Calculation

Biomics Biopharma's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: . 20 )	/	( (Total Assets (A: . 20 )	+	Total Assets (A: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

Biomics Biopharma's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: . 20 )	/	( (Total Assets (Q: . 20 )	+	Total Assets (Q: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Biomics Biopharma Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomics Biopharma (ASX:BBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

ASX:G88 ASX:ELS ASX:BHD ASX:IBX ASX:ZEN ASX:OLI ASX:KPG ASX:CAN ASX:MPW ASX:CQG ASX:OCA

Traded in Other Exchanges

N/A

Address

1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000

Website

http://www.biomics.com

Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines